As part of Cheddar's Crypto Craze series we dive into the latest news in this evolving space, and trends impacting the markets. In this episode Cheddar's Hope King and Brad Smith explore how the major cryptocurrencies are performing, and why some researchers are bullish on Bitcoin. Plus, how regulators are looking to crack down on this space.
It was a relatively flat week for the three major cryptocurrencies Bitcoin, Ethereum, and Ripple's XRP. Canaccord Genuity Managing Director Michael Graham explains the latest trends in the market and his outlook for the year ahead.
Graham cites increased regulation in South Korea and China as driving prices down from all-time highs. "For the last couple week's we've been sort-of recovering from all that," explains Graham.
Entrepreneur and Choose Yourself Financial Founder James Altucher has a bold prediction for Bitcoin. Altucher predicts Bitcoin could reach between $100,000 to $300,000 by the end of 2018. He explains the argument for his bullish stance on this cryptocurrency, and addresses promises he is making to his subscribers.
Altucher defended his business strategy to lure subscribers with flashy commercials. Altucher says that his investment return guarantee newsletter is a strategy to educate the masses on Bitcoin.
"I'm a big believer that people need to be educated on what Bitcoin and cryptocurrencies are, and the effect they are going to have on society," said Altucher.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
